Avalo Therapeutics Inc (AVTX)
12.97
+0.76
(+6.22%)
USD |
NASDAQ |
Apr 23, 16:00
12.89
-0.08
(-0.62%)
After-Hours: 20:00
Avalo Therapeutics Profit Margin (Quarterly): -1.43K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.43K% |
| September 30, 2023 | -2.22K% |
| June 30, 2023 | -1.27K% |
| March 31, 2023 | -2.10K% |
| December 31, 2022 | -1.10K% |
| September 30, 2022 | 21.35% |
| June 30, 2022 | -1.26K% |
| March 31, 2022 | -1.88K% |
| December 31, 2021 | -8.77K% |
| September 30, 2021 | -1.29K% |
| June 30, 2021 | -509.8% |
| March 31, 2021 | -6.49K% |
| December 31, 2020 | -1.04K% |
| September 30, 2020 | -1.21K% |
| June 30, 2020 | -992.6% |
| March 31, 2020 | -766.8% |
| Date | Value |
|---|---|
| December 31, 2019 | |
| September 30, 2019 | -182.5% |
| June 30, 2019 | -447.1% |
| March 31, 2019 | -289.3% |
| December 31, 2018 | 88.04% |
| September 30, 2018 | -603.8% |
| June 30, 2018 | -125.5% |
| March 31, 2018 | -86.62% |
| December 31, 2017 | -138.4% |
| September 30, 2017 | 74.77% |
| June 30, 2017 | -1.14K% |
| March 31, 2017 | -510.3% |
| December 31, 2016 | -905.4% |
| September 30, 2016 | -1.92K% |
| June 30, 2016 | -541.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-8.77K%
Minimum
Dec 2021
21.35%
Maximum
Sep 2022
-1.83K%
Average
-1.23K%
Median
Profit Margin (Quarterly) Benchmarks
| Imunon Inc | -- |
| iBio Inc | -- |
| Kodiak Sciences Inc | -- |
| Petros Pharmaceuticals Inc | -87.34% |
| Ocugen Inc | -157.3% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -109.5% |
| Return on Invested Capital | -308.4% |
| Operating Margin (Quarterly) | -656.9% |
| Return on Net Operating Assets | -188.3% |